SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is currently experiencing high volatility as investors weigh President Trump's recent vocal endorsement of the company's defense capabilities against a persistent short thesis led by Michael Burry. The community remains deeply divided, with bulls pointing to the company's strategic entrenchment in military operations as a long-term moat, while bears continue to pressure the stock based on valuation concerns and competitive threats in the AI software sector.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community speculation following a rapid valuation surge that has triggered massive liquidations of short positions. The discussion is sharply divided between believers in the project's decentralized music-event utility and skeptics who are warning of a potential pump-and-dump scheme.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point of intense community discussion, driven by its ongoing ecosystem expansion and a surge in speculative interest surrounding new token launches on the network. Traders remain deeply divided, with some actively building long-term positions while others engage in highly leveraged short-term plays, mirroring the broader market's heightened sensitivity to macroeconomic and geopolitical volatility.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is actively rallying behind the token's multichain capabilities and deflationary burn mechanism, viewing it as a prominent meme coin opportunity. Supporters are driving engagement through social media campaigns, emphasizing the project's organic growth and potential for future expansion.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging to new all-time highs as institutional conviction grows, driven by a massive deal pipeline with hyperscalers and a strategic pivot toward an integrated AI full-stack platform. The community is actively debating the stock's parabolic trajectory, with many investors highlighting the company's aggressive infrastructure expansion while others remain cautious, watching for potential volatility and profit-taking opportunities amid shifting macro conditions.

Maulcoin

Maulcoin is trending as a community-driven "culture coin" that has gained significant traction on social sentiment platforms despite lacking a formal price chart. Holders are actively discussing their long-term conviction, referring to themselves as "Maulers" while organizing to build support, manage liquidity, and execute coordinated buying efforts in pursuit of a zero-erasing movement.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is currently experiencing intense volatility fueled by massive investor interest in the semiconductor and photonics sectors, with the community actively debating whether the stock's parabolic climb is a sustainable re-rating or an overextended bubble primed for a sharp correction. Much of the discourse centers on conflicting narratives regarding the company's valuation versus its role in critical AI infrastructure, leading to a high-stakes standoff between retail bulls betting on long-term hyperscaler growth and bears focusing on insider selling and potential dilution risks.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

Dave Inc. (DAVE) is trending as investors digest a strong earnings report and the company's aggressive move to increase its share repurchase program, sparking intense debate over its valuation and growth prospects. While the community is actively debating the stock's potential for a technical rebound, sentiment is polarized between long-term bulls highlighting robust AI-driven underwriting and cash flow, and skeptics pointing to recent volatility, legal developments, and broader concerns regarding fintech credit risk.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is trending as investors weigh an analyst upgrade and bullish community sentiment regarding its AI infrastructure role against broader market volatility and concerns over copper-versus-optical networking shifts. The community is actively discussing the company's strong fundamentals and potential undervaluation while debating the competitive landscape of next-gen data center connectivity.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is seeing mixed sentiment as the community debates its long-term viability, with vocal supporters pointing to institutional interest and potential ETF filings, while critics express frustration over stagnant price action and dilution. Traders are also actively discussing the Cronos blockchain's meme coin ecosystem, specifically highlighting 'crow with knife' ($CAW) and $MERY as high-volatility plays that many are watching for potential breakout opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the firm...

Capricorn Fund Managers Ltd Decreases Position in Tarsus Pharmaceuticals, Inc. $TARS

Capricorn Fund Managers Ltd lessened its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 90.8% during the 4th quarter, according to the company in its most recent Form 13F...

Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Tarsus Pharmaceuticals from a "hold" rating to a "buy" rating in a research report on Saturday...

Q2 EPS Estimate for Tarsus Pharmaceuticals Lifted by Analyst

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) - Lifesci Capital increased their Q2 2026 EPS estimates for shares of Tarsus Pharmaceuticals in a research note issued on Tuesday, March 24th...

Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent 13F...

Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade

Key PointsAn executive at Tarsus Pharmaceuticals sold 12,274 shares for a transaction value of approximately $839,000, based on a weighted average price of $68.36 per share across three days ending March 19, 2026...

Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Sells $761,676.24 in Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) CEO Bobak Azamian sold 10,972 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $761,676.24. Following the completion of the transaction, the...

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 390 Shares

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 390 shares of the firm's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $67.00, for a total value of $26,130.00. Following the sale, the insider directly owned...

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 375 Shares

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 375 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total transaction of $26,032.50. Following the transaction...

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $26,041.09 in Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 379 shares of the company's stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $68.71, for a total transaction of $26,041.09. Following the completion of the...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.30	--	--	N/A
Q4 '25	-$0.09	-$0.20	-115.11%	MISSED
Q3 '25	-$0.35	-$0.30	14.14%	BEAT
Q2 '25	-$0.38	-$0.48	-26.79%	MISSED
Q1 '25	-$0.73	-$0.64	12.31%	BEAT

TARS
Tarsus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest TARS News

TARSTarsus Pharmaceuticals Inc